Abstract
alpha-Synuclein (alphasyn) mutations, overexpression, misfolding, and aggregation are associated with Parkinson's disease. This protein has been intensively studied in neuronal systems. However, alphasyn is also present in extracellular fluids, such as cerebrospinal fluid and blood plasma. Recent studies have attempted to quantify its levels and compare these in various extracellular fluids of control and Parkinson's disease subjects. Data from these studies have been difficult to interpret, suggesting that more sensitive, standardized, and well-characterized assays of larger cohorts are required. Here, we describe the development of a new ELISA specifically for quantifying alphasyn in human plasma. An initial assay, using a commercial anti-alphasyn monoclonal antibody (211; Santa Cruz Biotechnology, Santa Cruz, CA) and based on a published protocol, was adapted for use in human plasma. In addition, we have developed a novel alphasyn-specific antibody for the assay that has very high sensitivity and signal:noise characteristics. Assays with either antibody showed high specificity for alphasyn, and detected it in a variety of sample types, including plasma. These assays can now be employed on large cohorts of patients and contro...Continue Reading
References
Jun 8, 2000·Neuroscience Letters·R BorghiM Tabaton
Oct 2, 2003·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
May 26, 2004·Neurology·D W MillerA B Singleton
Jan 25, 2005·Neuroscience Letters·David W MillerOkan Dogu
May 18, 2005·Alcoholism, Clinical and Experimental Research·Dominikus BönschStefan Bleich
Feb 9, 2006·Journal of Neural Transmission·P H LeeK Huh
Mar 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Omar M A El-AgnafDavid Allsop
Aug 26, 2006·Biochemical and Biophysical Research Communications·Takahiko TokudaOmar M A El-Agnaf
Jan 12, 2007·Proceedings of the National Academy of Sciences of the United States of America·Clemens R ScherzerSteven R Gullans
Jan 30, 2007·Experimental Neurology·Qiao-Xin LiMalcolm K Horne
Jun 15, 2007·Scandinavian Journal of Clinical and Laboratory Investigation·A Winther FjorbackP Henning Jensen
Dec 7, 2007·Drug and Alcohol Dependence·Deborah C MashFrank R Ervin
Dec 29, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Julia FuchsThomas Gasser
Jul 16, 2008·Experimental Neurology·Brit MollenhauerMichael G Schlossmacher
Nov 22, 2008·Neuroscience Letters·Annika OhrfeltHenrik Zetterberg
Citations
Feb 9, 2012·The Journal of Biological Chemistry·Bruno FauvetHilal A Lashuel
Jan 10, 2013·PloS One·Ana GorostidiOmar M A El-Agnaf
Jul 8, 2014·PloS One·Patrick Aldrin-KirkTomas Björklund
Apr 7, 2015·PloS One·Niklas K U KoehlerElke Richartz-Salzburger
Nov 24, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Sireesha ManneAnumantha G Kanthasamy
Oct 11, 2015·Journal of Neurochemistry·Brit MollenhauerMichael G Schlossmacher
Jul 17, 2018·Molecular Neurobiology·Thein Than HtikeBalázs Gulyás
Nov 17, 2020·ACS Chemical Neuroscience·Benjamin W SchlichtmannBalaji Narasimhan